APR Nov/Dec 2022 - 9

AMERICAN PHARMACEUTICAL REVIEW
Social Media Connections
U.S. FDA
@US_FDA
#DYK African American and Hispanic/Latino populations
are disproportionately affected by #Alzheimers?
Learn more about the symptoms and risk factors via
@FDAHealthEquity https://ow.ly/o3uS50LwrX2
#AlzheimersAwarenessMonth
BioNTech SE
@BioNTech_Group
We published new data on the immune response induced
by our Omicron BA.4/BA.5-adapted bivalent #COVID19
vaccine against newer Omicron sublineages, incl. BA.4.6,
BA.2.75.2, BQ.1.1 & XBB.1. https://investors.biontech.de/
news-releases/news-release-details/pfizer-and-biontechreport-new-data-omicron-ba4ba5-adapted
U.S.
Pharmacopeia
@USPharmacopeia
Obstacles manufacturers can face when considering
adoption of pharmaceutical continuous manufacturing
include workforce capacity challenges, lack of clarity
on return-on-investment, regulatory uncertainties, and
internal resistance to change. Learn more. https://bit.
ly/3tn1UyV
Pfizer Inc.
@pfizer
A common misconception you may see on the Internet
is that #COVID19 vaccines and treatments for COVID-19
are one in the same - the truth is that they serve different
purposes. Our scientist friend Darrion breaks down the
difference between COVID-19 vaccines and treatments.
https://twitter.com/i/status/1595139236402954241
PhRMA
@PhRMA
The need for new antimicrobials has never been greater
- with drug-resistant infections on the rise amid
#COVID19. Six of the 18 most alarming AMR threats
cost the U.S. more than $4.6 billion annually, and the
PASTEUR Act can help. http://bit.ly/3tzCPkh
EU Medicines Agency
@EMA_News
Are you a #ClinicalTrial sponsor? As of 31 January 2023, you
will have to use the Clinical Trials Information System and
follow the same process to apply for the authorisation of a
clinical trial in the #EEA.
American Association of
Pharmaceutical Scientists
@AAPSComms
Time is running out to #volunteer. AAPS seeks
experienced scientists like you to lead the NBC
Abstract Screening Committee. This Committee selects
the poster abstracts that will bring novel science to the
National Biotechnology Conference (#NBC2023).
Merck
@Merck
For clinical researcher Janethe Pena, unmet needs in patient
health serve as an urgent call to action. Learn about her
work in pulmonary arterial hypertension: merck.us/3zuZuBJ
#PHAwarenessMonth
Connect with American Pharmaceutical Review at:
facebook.com/AmericanPharmaceuticalReview
twitter.com/ampharmrev
linkedin.com/groups/American-Pharmaceutical-Review-3889659
www.americanpharmaceuticalreview.com |
| 9

https://www.ow.ly/o3uS50LwrX2 https://investors.biontech.de/ https://bit https://www.twitter.com/i/status/1595139236402954241 http://www.bit.ly/3tzCPkh http://www.merck.us/3zuZuBJ http://www.facebook.com/AmericanPharmaceuticalReview http://www.twitter.com/ampharmrev http://www.linkedin.com/groups/American-Pharmaceutical-Review-3889659 http://www.americanpharmaceuticalreview.com

APR Nov/Dec 2022

Table of Contents for the Digital Edition of APR Nov/Dec 2022